NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
TAGWORKS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TAGWORKS
ST13
US500000090873410Class
1, 5, 42
Filing
90873410
Registration
7265620
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/09/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
08/09/2021
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Nijmegen, NL
Examiner
ALTREE, NICK
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Tagworks Pharmaceuticals BV
Representatives
Michael Fedrick LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical preparations for use in industry and science; chemical preparations and kits comprised of chemical preparationsfor use in modifying or isolating biological materials; chemical preparations for solid phase chemistry or separation technologysuch as coated polymersin bead or resin formfor use in manufacturing
Class 5
pharmaceutical and veterinary preparationsT-cell engaging biologics or drug conjugates based on biologics for therapybiologics for immunoimagingimmunotherapy; pharmaceutical and veterinary preparationsantibodiesantibody fragmentspeptides or small molecules for immunotherapy treatment; pharmaceutical and veterinary nanoparticlespolymersliposomesantibodies modified with a chemical tag or a radiolabeled chemical tagfor nuclear imaging or therapy; pharmaceutical preparations for treatment or prevention of cancerautoimmune or infectious disease; pharmaceutical and chemical preparations for medical purposeschemical probes or chemical tags conjugated to biologics for the treatment of cancerautoimmune diseaseinfectious disease; sanitary preparations for medical purposes; biopharmaceutical preparations for use in human and veterinary medicine for treatment of cancerautoimmune diseases and infectious diseases; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemicals and biological substances for medical usediagnostic reagents; pharmaceutical and veterinary preparationsimmune cell engaging biologicspreparations for imagingprodrugsdrug conjugates based on biologics for therapybiologicspeptides or small molecules for radiotherapyimmunotherapy or chemotherapy; pharmaceutical and veterinary nanoparticlespolymersliposomesbiologicspeptidessmall molecules modified with a chemical tag or linker or a radiolabelled chemical tagfor nuclear imaging or therapy; pharmaceutical and chemical preparations for medical purposeschemical probes or chemical tags or linkers conjugated to biologics for the treatment of cancerautoimmune diseaseinfectious disease
Class 42
scientific and technological research in the field of immunoimaging and immunotherapy to provide T-cell engaging biologics or preparations for imaging or drug conjugates based on antibodiesantibody fragmentspeptidesnanoparticle polymers or nanoparticle liposomesradiolabeled antibodies for nuclear imaging or therapyto provide preparations for medical diagnostics; scientific and technological researchin the field of imaging or immunotherapy to provide immune-cell engaging biologics or preparations for imaging or drug conjugates based on biologics for therapyantibodiesantibody fragmentspeptidessmall moleculesnanoparticle polymers or nanoparticle liposomesradiolabelled antibodiesbiologicspeptides and small molecules for nuclear imaging or therapyto provide preparations for medical diagnostics
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/04/2023
NOAC
CORRECTED NOA E-MAILED
09/19/2023
ICNA
NOTICE OF ALLOWANCE CORRECTION ENTERED
09/18/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/23/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/23/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/20/2023
INOA
AMENDMENT AFTER NOA NOT ENTERED
06/16/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/16/2023
EX1G
SOU EXTENSION 1 GRANTED
06/16/2023
EXT1
SOU EXTENSION 1 FILED
06/16/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/16/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/11/2022
GNRT
NON-FINAL ACTION E-MAILED
05/11/2022
CNRT
NON-FINAL ACTION WRITTEN
05/11/2022
DOCK
ASSIGNED TO EXAMINER
05/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2021
NWAP
NEW APPLICATION ENTERED
08/12/2021
Continuous trademark protection
Get notified about every new filing that threatens TAGWORKS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.